Elisabeth Baugh, Ovarian Cancer Champion, to Retire
CCRA members congratulate Elisabeth Baugh on her pending retirement as CEO of Ovarian Cancer Canada. Elisabeth has been at the helm of the organization since its founding. Under Elisabeth’s leadership, Ovarian Cancer Canada has grown its national presence and her commitment to women living with ovarian cancer and passion for advancing game-changing research helped secure federal and partnered funding for OvCAN. This initiative is focused on finding the best research models for ovarian cancer, identifying the most promising novel treatments, and advancing clinical trials using a personalized medicine approach.
Beyond Canada, Elisabeth chaired the first ever World Ovarian Cancer Day in 2013 and has served as chair of the World Ovarian Cancer Coalition since its inception, working to increase the international profile of this important cause.
We wish Elisabeth the very best in upcoming retirement. She will be missed at the CCRA table.

Effective January 1st, 2021, CCRA welcomes new Advisory Board chair, Dr. Paula Robson. Paula is the Scientific Director of the Cancer Strategic Clinical Network, and Scientific Director and co-lead of Cancer Research & Analytics for Cancer Care Alberta in Alberta Health Services....
The CCRA congratulates Drs. Anne-Marie Mes-Masson and John Bell, two distinguished cancer researchers and past CCRA awardees, for their appointments as Officers of the Order of Canada in late December 2025.
Anne-Marie Mes-Masson, PhD, FCAHS, FRSC, Associate Scientific Director of ...